Skip to content

Efficacy of ultrasound-guided transversus abdominis plane (TAP) block as postoperative analgesia in unilateral hernioplasty surgery: a randomized controlled trail

Efficacy of ultrasound-guided transversus abdominis plane (TAP) block as postoperative analgesia in unilateral hernioplasty surgery: a randomized controlled trail

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001192
Enrollment
Unknown
Registered
2011-02-23
Start date
2011-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain

Interventions

Group A:0.9% NaCl surgery side transversus abdominis plane block
Group B:0.1% ropivacaine surgery side transversus abdominis plane block
Group C:0.25% ropivacaine surgery side transversus abdominis plane block
Group D:0.375% ropivacaine surgery side transversus abdominis plane block
Group E:0.5% ropivacaine surgery side transversus abdominis plane block

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old; 2. ASA I/II; 3. Underwent unilateral hernioplasty surgery; 4. Suitable for local anaethesia; 5. Negative of cognitive/expressive dysfunction, accept post-operative analgesia out of free will, and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Reject relative procedure; 2. Procedure failed.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scales;Satisfaction of analgesia;Using of remedial medicine;

Secondary

MeasureTime frame
Plane of blocking;First time of flatus/ defecation;First time of pain feeled;First time of standing/ walking with assistance;Vital signs;

Countries

China

Contacts

Public ContactYi Feng
yifeng65@sina.com+86 010 88325581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026